Makras P - Search Results

1

Polyzos SA, Anastasilakis AD, Efstathiadou ZA, Makras P, Perakakis N, Kountouras J, Mantzoros CS. Polyzos SA, et al. Among authors: makras p. Endocrine. 2018 Feb;59(2):260-274. doi: 10.1007/s12020-017-1476-1. Epub 2017 Nov 23. Endocrine. 2018. PMID: 29170905 Review.

2

A case report of subacute thyroiditis during pregnancy: difficulties in differential diagnosis and changes in cytokine levels.

Anastasilakis AD, Karanicola V, Kourtis A, Makras P, Kampas L, Gerou S, Giomisi A. Anastasilakis AD, et al. Among authors: makras p. Gynecol Endocrinol. 2011 Jun;27(6):384-90. doi: 10.3109/09513590.2010.493963. Epub 2010 Jun 9. Gynecol Endocrinol. 2011. PMID: 20528573 Free article.

3

Distinctive growth pattern in a patient with a delayed diagnosis of Langerhans' cell histiocytosis.

Anastasilakis AD, Kaltsas GA, Delimpasis G, Wilkens L, Kanakis G, Makras P. Anastasilakis AD, et al. Among authors: makras p. Pituitary. 2012 Dec;15 Suppl 1:S28-32. doi: 10.1007/s11102-011-0291-6. Pituitary. 2012. PMID: 21279449

4

No effect of rosuvastatin in the zoledronate-induced acute-phase response.

Makras P, Anastasilakis AD, Polyzos SA, Bisbinas I, Sakellariou GT, Papapoulos SE. Makras P, et al. Calcif Tissue Int. 2011 May;88(5):402-8. doi: 10.1007/s00223-011-9468-2. Epub 2011 Feb 9. Calcif Tissue Int. 2011. PMID: 21305270 Clinical Trial.

5

Denosumab and bisphosphonates: rivals or potential "partners"? A "hybrid" molecule hypothesis.

Anastasilakis AD, Polyzos SA, Anastasilakis CD, Toulis KA, Makras P. Anastasilakis AD, et al. Among authors: makras p. Med Hypotheses. 2011 Jul;77(1):109-11. doi: 10.1016/j.mehy.2011.03.039. Epub 2011 Apr 8. Med Hypotheses. 2011. PMID: 21482033

6

Reduced bone mineral density in adult patients with Langerhans cell histiocytosis.

Makras P, Terpos E, Kanakis G, Papatheodorou A, Anastasilakis AD, Kokkoris P, Kaltsas GA. Makras P, et al. Pediatr Blood Cancer. 2012 May;58(5):819-22. doi: 10.1002/pbc.23166. Epub 2011 May 5. Pediatr Blood Cancer. 2012. PMID: 21548013

7

Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment.

Polyzos SA, Anastasilakis AD, Makras P, Terpos E. Polyzos SA, et al. Among authors: makras p. Exp Clin Endocrinol Diabetes. 2011 Oct;119(9):519-24. doi: 10.1055/s-0031-1284365. Epub 2011 Aug 2. Exp Clin Endocrinol Diabetes. 2011. PMID: 21811962 Review.

8

Targeting the osteoblast: approved and experimental anabolic agents for the treatment of osteoporosis.

Toulis KA, Anastasilakis AD, Polyzos SA, Makras P. Toulis KA, et al. Among authors: makras p. Hormones (Athens). 2011 Jul-Sep;10(3):174-95. doi: 10.14310/horm.2002.1308. Hormones (Athens). 2011. PMID: 22001129 Free article. Review.

9

Is serum IL-17A a useful systemic biomarker in patients with Langerhans cell histiocytosis?

Makras P, Polyzos SA, Anastasilakis AD, Terpos E, Papatheodorou A, Kaltsas GA. Makras P, et al. Mol Ther. 2012 Jan;20(1):6-7. doi: 10.1038/mt.2011.239. Mol Ther. 2012. PMID: 22215051 Free PMC article. No abstract available.

10

Serum osteoprotegerin, RANKL, and Dkk-1 levels in adults with Langerhans cell histiocytosis.

Makras P, Polyzos SA, Anastasilakis AD, Terpos E, Kanakis G, Schini M, Papatheodorou A, Kaltsas GA. Makras P, et al. J Clin Endocrinol Metab. 2012 Apr;97(4):E618-21. doi: 10.1210/jc.2011-2962. Epub 2012 Jan 25. J Clin Endocrinol Metab. 2012. PMID: 22278426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters